Gait Parameters Analysis in Post-stroke Patients and in Elderly Fallers (GAITRITE)

June 14, 2021 updated by: Assistance Publique - Hôpitaux de Paris

Study of the Temporospatial Gait Parameters With the Electronic Carpet "GAITRite" in Patients With Walking Impairment After Stroke and in Old Faller Subjects

A large proportion of falls in older people occurs when walking. Most studies have recently demonstrated correlation between the variations in spatiotemporal gait parameters and fall risk in elderly and in several diseases. The investigators objective is to analyse this parameters in population with gait stability disorders (post-stroke patients and fallers) to identify the most valuable and to develop/test a conglomerate stability score.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Temporal-spatial gait parameters will be recorded in subjects aged 65-80 years : 30 healthy people, 30 patients at least one year post-stroke, and 30 fallers while walking on an electronic walkway GAITRite® at self-selected speed.

Study Type

Observational

Enrollment (Actual)

62

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Paris, France, 75010
        • PRM Department - Lariboisiere Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 80 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

subjects aged 65-80 years : 30 healthy people, 30 patients at least one year post-stroke, and 30 fallers

Description

  1. For healthy subjects

    • Aged 65 to 80 years (included) ;
    • Patient has been informed and has signed the consent form.

  2. For post-stroke patients

    • Aged 65 to 80 years (included) ;
    • Stroke patients who had only one cerebrovascular accident, at least one year before inclusion ;
    • Able to walk without using assisting devices or ambulatory aids ;
    • No cardiovascular contraindication ;
    • No history of neurological diseases with influence on walking capacities (excepted stroke) ;
    • No history of vestibular or orthopaedic (lower limb) disorders ;
    • No amblyopia ;
    • Patient has been informed and has signed the consent form.

  3. For fallers

    • Aged 65 to 80 years (included) ;
    • Reported 2 or more falls within 6 months prior to the beginning of the study ;
    • Able to walk without using assisting devices or ambulatory aids ;
    • No cardiovascular contraindication ;
    • No history of neurological diseases with influence on walking capacities ;
    • No history of vestibular or orthopaedic (lower limb) disorders ;
    • No amblyopia ;
    • Patient has been informed and has signed the consent form.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
post-stroke patients
Stroke patients who had only one cerebrovascular accident, at least one year before inclusion and Able to walk without using assisting devices or ambulatory aids
Other: Gait analysis
walking on an electronic walkway GAITRite® at self-selected speed
healthy subjects
Aged 65 to 80 years
Other: Gait analysis
walking on an electronic walkway GAITRite® at self-selected speed
fallers
Reported 2 or more falls within 6 months prior to the beginning of the study and Able to walk without using assisting devices or ambulatory aids
Other: Gait analysis
walking on an electronic walkway GAITRite® at self-selected speed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
GAIT parameters
Time Frame: at inclusion
Spatiotemporal gait parameters registered by a GAITRite walkway system, including mean and coefficient of variation for step and cycle length and time, base of support, speed, cadence, single and double support phase, stance and swing phase.
at inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Ambulation Performance Score
Time Frame: at inclusion
a score which represents a quantification of patients' gait based on a selection of spatiotemporal parameters obtained at a self-selected speed.
at inclusion
Rivermead Motricity Index
Time Frame: at inclusion
For post-stroke patients
at inclusion
Berg Balance Scale
Time Frame: at inclusion
For post-stroke patients
at inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Alain Yelnik, PRM department

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2010

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

May 4, 2011

First Submitted That Met QC Criteria

September 28, 2011

First Posted (Estimate)

September 29, 2011

Study Record Updates

Last Update Posted (Actual)

June 15, 2021

Last Update Submitted That Met QC Criteria

June 14, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UC1002

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Gait analysis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe